Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2009
10/22/2009US20090264432 Piperidine and Morpholine Renin Inhibitors
10/22/2009US20090264431 Novel cathepsin c inhibitors and their use
10/22/2009US20090264429 Aryl - Hydroxyethylamino - Pyrimidines and Triazines as Modulators of Fatty Acid amide Hydrolase
10/22/2009US20090264428 Renin Inhibitors
10/22/2009US20090264427 3-Cyanoquinolines, Methods for Preparation and Use as Insulin-like Growth Factor Inhibitors
10/22/2009US20090264426 Bicyclic aromatic substituted pyridone derivative
10/22/2009US20090264425 Chemical compounds
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090264423 Serine-threonine protein kinase and parp modulators
10/22/2009US20090264418 such as [5-(4-cyclopentyl-piperazine-1-carbonyl)-1H-indol-2-yl]-pyrrolidin-1-yl-methanone, useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors
10/22/2009US20090264416 N-benzyl,n'-arylcarbonylpiperazine derivatives
10/22/2009US20090264415 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment
10/22/2009US20090264414 Amide Derivatives and Pharmaceutical Use Thereof
10/22/2009US20090264410 Therapeutic compounds and uses thereof
10/22/2009US20090264407 Substituted Sulfonamide Compounds
10/22/2009US20090264406 3-methyl-imidazo[1,2-b]pyridazine derivatives
10/22/2009US20090264405 Cetp Inhibitors
10/22/2009US20090264402 Novel diphenylazetidinone substituted by piperazine-1-sulfonic acid and having improved pharmacological properties
10/22/2009US20090264401 Substituted pyrimidin-5-carboxamides 281
10/22/2009US20090264399 Heterocyclic janus kinase 3 inhibitors
10/22/2009US20090264315 Dipeptide mimics, libraries combining two dipeptide mimics with a third group, and methods for production thereof
10/22/2009US20090263438 Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives
10/22/2009US20090263353 Novel Sulphonylpyrroles as Inhibitors of Hdac S Novel Sulphonylpyrroles
10/22/2009CA2721371A1 Small molecule inhibitors of the pleckstrin homology domain and methods for using same
10/22/2009CA2721339A1 Activating agent for peroxisome proliferator activated receptor
10/22/2009CA2720524A1 Pyrrolidinone glucokinase activators
10/22/2009CA2720215A1 Novel estrogen receptor ligands
10/22/2009CA2719789A1 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors
10/22/2009CA2719785A1 Ether benzylidene piperidine aryl carboxamide compounds
10/22/2009CA2719784A1 Ether benzylidene piperidine 5-membered aryl carboxamide compounds
10/22/2009CA2719515A1 A novel benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and a use thereof
10/22/2009CA2718538A1 Quinoline derivatives as axl kinase inhibitors
10/22/2009CA2717087A1 4-[3-(aryloxy)benzylidene]-3-methyl piperidine 5-membered aryl carboxamides
10/22/2009CA2716886A1 4-[3-(aryloxy)benzylidene]-3-methyl piperidine aryl carboxamide compounds
10/21/2009EP1971601B1 N4-phenyl-quinazoline-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
10/21/2009EP1515724B1 Mitotic kinesin inhibitors
10/21/2009EP1492785B9 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
10/21/2009EP1426365B9 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
10/21/2009CN101563340A 2-benzimidaz0lyl-6-m0rph0lin0-4-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders
10/21/2009CN101563338A MAPK/ERK kinase inhibitors
10/21/2009CN101563332A Substituted dimethylcyclobutyl compounds, their preparation and use in medicaments
10/21/2009CN101560209A Oxazolidinone compound containing pyridine and preparation method thereof
10/21/2009CN101560193A Alpha-polyhalide acetyl piperazinyl oxazolidone compound and antibacterium application thereof
10/21/2009CN101559053A 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
10/20/2009US7605273 P38 map kinase inhibitors; inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease, and congestive heart failure
10/20/2009US7605272 N-{2-[2-(1H-indazol-3-yl)vinyl]-5-(4-methylpiperazin-1-ylmethyl)phenyl}-3-methylthiophene-2-carboxamide; type I insulin-like growth factor receptor inhibitors; anticarcinognenic agents; colon, pancreatic cancers; antitumor agents; hematopoietic tumors; industrial scale
10/20/2009US7605176 β-ketoamide compounds with MCH antagonistic activity
10/20/2009US7605171 (3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists
10/20/2009US7605164 Compositions and methods for treating heart failure
10/20/2009US7605162 Indole-3-alkyl-N-piperazine ring substituted with quinoline ring or derivatives; high affinity for both the dopamine D2 receptor and the serotonin reuptake site; nervous system disorders, such as anxiety disorders, depression, Parkinson's disease, and schizophrenia
10/20/2009US7605159 Cathepsin cysteine protease inhibitors and their use
10/20/2009US7605158 Carbamoyl-type benzofuran derivatives
10/20/2009US7605155 Enzyme inhibitors from pyrazolo[1,5a]pyrimidine as enzyme inhibitors; cyclin dependent kinases (CDKs) inhibitors; cancer, inflammation and arthritis; neurodegenerative diseases such Alzheimer's; cardiovascular, viral and fungal diseases
10/20/2009US7605154 Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitors
10/20/2009US7605150 Drug therapy for Celiac Sprue
10/20/2009US7605111 Herbicides
10/20/2009US7604874 having an anthracene compound substituted with at least one thiophenyl ring; OLED organic light emitters; as displays with low power consumption, faster response time, higher brightness level, unlimited viewing angle
10/20/2009CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection
10/20/2009CA2407371C Quinazoline derivatives for the treatment of tumours
10/20/2009CA2385130C Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases
10/20/2009CA2378183C Antibacterial heterobicyclic substituted phenyl oxazolidinones
10/20/2009CA2214793C Novel intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds
10/15/2009WO2009126635A1 2-amino-benzothiazole derivates useful as inhibitors of rock kinases
10/15/2009WO2009126003A2 Novel pyrazole and benzoxazole-substituted pyridine derivatives or pharmaceutically acceptable salts thereof, preparation process for same, and pharmaceutical composition for prevention and treatment of disorders involving aberrant cell proliferation containing same as active ingredients
10/15/2009WO2009125940A2 Photoactive compound and photosensitive resin composition comprising the same
10/15/2009WO2009125861A1 Cysteine protease inhibitor
10/15/2009WO2009125853A1 Homocysteine synthase inhibitor
10/15/2009WO2009125808A1 Aminocyclohexyl derivative
10/15/2009WO2009125434A2 Oxime derivatives
10/15/2009WO2009124962A2 Sulfonamides
10/15/2009WO2009124903A1 Substituted pyridazinylmethyl sulfonamides
10/15/2009WO2009124692A1 New substituted spiro[cycloalkyl-1,3'-indol]-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors.
10/15/2009WO2009105214A3 Selective androgen receptor modulators
10/15/2009WO2009093269A9 Novel heterocyclic compounds
10/15/2009US20090258913 Triazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1
10/15/2009US20090258901 Ligands for monoamine receptors and transporters, and methods of use thereof
10/15/2009US20090258885 Diphenylmethane Derivatives as Inhibitors of Leukotriene Biosynthesis
10/15/2009US20090258884 Substituted amides
10/15/2009US20090258868 Heterocyclic aspartyl protease inhibitors
10/15/2009US20090258857 Chemical compounds
10/15/2009US20090258856 Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
10/15/2009US20090258855 Bicyclic triazoles as protein kinase modulators
10/15/2009US20090258852 Inhibitors of Checkpoint Kinases
10/15/2009US20090258851 Diaryl substituted alkanes
10/15/2009US20090258016 Substituted imidazole derivatives
10/15/2009CA2725425A1 Homocysteine synthase inhibitor
10/15/2009CA2720530A1 Sulfonamides
10/14/2009EP2108642A1 Jak inhibitor
10/14/2009EP2108641A1 New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
10/14/2009EP2108014A1 Method of preparing docetaxel and intermediates used therein
10/14/2009EP1893603B1 Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists
10/14/2009EP1856082B1 Glucopyranosyl-substituted ((hetero)arylethynyl-benzyl)-benzene derivatives and use thereof as sodium-dependent glucose cotransporter 2 (sglt2) inhibitors
10/14/2009EP1720829B1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
10/14/2009EP1658267B1 Inhibitors of cathepsin s
10/14/2009CN101558065A Oxazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
10/14/2009CN101558064A Sulfonyl-phenyl-2h-[1,2,4]oxodiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals
10/14/2009CN101558058A Modulators of CB1 receptors
10/14/2009CN101558051A Method of preparing docetaxel and intermediates used therein
10/14/2009CN101558049A Substituted pyrazole and triazole compounds as KSP inhibitors
10/14/2009CN101555246A Halogen-containing asymmetry phthalocyanines compound, preparation method and application thereof
1 ... 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 ... 647